All Relations between Alzheimer Disease and bdnf

Publication Sentence Publish Date Extraction Date Species
Tadahiro Numakawa, Ryutaro Kajihar. An Interaction between Brain-Derived Neurotrophic Factor and Stress-Related Glucocorticoids in the Pathophysiology of Alzheimer's Disease. International journal of molecular sciences. vol 25. issue 3. 2024-02-10. PMID:38338875. bdnf and its receptor trkb are extensively expressed in neurons of the central nervous system (cns), and the contribution of the bdnf/trkb system to neuronal function is evident; thus, its downregulation has been considered to be involved in the pathogenesis of alzheimer's disease (ad). 2024-02-10 2024-02-12 Not clear
Jiaxing You, Yinan Wang, Xinyue Chang, Yi Liu, Yu He, Xiya Zhou, Jinyan Zou, Meng Xiao, Mengyao Shi, Daoxia Guo, Ouxi Shen, Zhengbao Zh. Association between plasma brain-derived neurotrophic factor level and Alzheimer's disease: a Mendelian randomization study. Current neurovascular research. 2024-01-27. PMID:38279765. high brain-derived neurotrophic factor (bdnf) concentrations have been found to be associated with a decreased risk of alzheimer's disease (ad) in observational studies, but the causality for this association remains unclear. 2024-01-27 2024-01-29 Not clear
Veronika Matuskova, Katerina Veverova, Dylan J Jester, Vaclav Matoska, Zahinoor Ismail, Katerina Sheardova, Hana Horakova, Jiri Cerman, Jan Laczó, Ross Andel, Jakub Hort, Martin Vyhnale. Mild behavioral impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms. Alzheimer's research & therapy. vol 16. issue 1. 2024-01-26. PMID:38279143. mild behavioral impairment in early alzheimer's disease and its association with apoe and bdnf risk genetic polymorphisms. 2024-01-26 2024-01-29 human
Hideo Takekoshi, Masaki Fujishima, Taiki Miyazawa, Ohki Higuchi, Takahiko Fujikawa, Teruo Miyazaw. Simultaneous Intake of Chlorella and Ascidian Ethanolamine Plasmalogen Accelerates Activation of BDNF-TrkB-CREB Signaling in Rats. Molecules (Basel, Switzerland). vol 29. issue 2. 2024-01-23. PMID:38257270. bdnf expression is decreased in patients with alzheimer's disease (ad). 2024-01-23 2024-01-25 human
Anisha A DSouza, Praveen Kulkarni, Craig F Ferris, Mansoor M Amiji, Benjamin S Bleie. Mild repetitive TBI reduces brain-derived neurotrophic factor (BDNF) in the substantia nigra and hippocampus: A preclinical model for testing BDNF-targeted therapeutics. Experimental neurology. 2024-01-20. PMID:38244886. clinical studies have consistently shown that neurodegenerative diseases (nds) such as parkinson's disease, alzheimer's disease, amyotrophic lateral sclerosis, and huntington's disease show absent or low levels of brain-derived neurotrophic factor (bdnf). 2024-01-20 2024-01-23 rat
Ioanna Zota, Konstantina Chanoumidou, Ioannis Charalampopoulos, Achille Gravani. Dynamics of myelin deficits in the 5xFAD mouse model for Alzheimer's disease and the protective role of BDNF. Glia. 2024-01-11. PMID:38205694. dynamics of myelin deficits in the 5xfad mouse model for alzheimer's disease and the protective role of bdnf. 2024-01-11 2024-01-13 mouse
Chiara Criscuolo, Elissavet Chartampila, Stephen D Ginsberg, Helen E Scharfma. Dentate gyrus granule cells show stability of BDNF protein expression in mossy fiber axons with age and resistance to Alzheimer's disease neuropathology in a mouse model. eNeuro. 2024-01-02. PMID:38164567. dentate gyrus granule cells show stability of bdnf protein expression in mossy fiber axons with age and resistance to alzheimer's disease neuropathology in a mouse model. 2024-01-02 2024-01-05 mouse
Chiara Criscuolo, Elissavet Chartampila, Stephen D Ginsberg, Helen E Scharfma. Dentate gyrus granule cells show stability of BDNF protein expression in mossy fiber axons with age and resistance to Alzheimer's disease neuropathology in a mouse model. eNeuro. 2024-01-02. PMID:38164567. hippocampal bdnf has been implicated in alzheimer's disease (ad) because hippocampal levels in ad patients and ad animal models are often downregulated, suggesting that reduced bdnf contributes to ad. 2024-01-02 2024-01-05 mouse
Irene Navarro-Lobato, Mariam Masmudi-Martín, Manuel F López-Aranda, Juan F López-Téllez, Gloria Delgado, Pablo Granados-Durán, Celia Gaona-Romero, Marta Carretero-Rey, Sinforiano Posadas, María E Quiros-Ortega, Zafar U Kha. Promotion of structural plasticity in area V2 of visual cortex prevents against object recognition memory deficits in aging and Alzheimer's disease rodents. Neural regeneration research. vol 19. issue 8. 2023-12-16. PMID:38103251. a knockdown of bdnf gene in rgs14414-treated aging rats and alzheimer's disease model mice caused complete loss in the upregulation of neuronal structural plasticity and in the prevention of orm deficits. 2023-12-16 2023-12-19 mouse
Veysel Tahiroğlu, Elif Uğur, Erkam Coşkun, Naci Ömer Alayunt, Gülşah Zorgö. Protective role of BDNF in Alzheimer's disease pathophysiology and its correlation with new biomarkers: Can the role of BDNF be re-discussed? Advances in clinical and experimental medicine : official organ Wroclaw Medical University. 2023-12-08. PMID:38062654. protective role of bdnf in alzheimer's disease pathophysiology and its correlation with new biomarkers: can the role of bdnf be re-discussed? 2023-12-08 2023-12-17 Not clear
Sama Jaberi, Margaret Fahnestoc. Mechanisms of the Beneficial Effects of Exercise on Brain-Derived Neurotrophic Factor Expression in Alzheimer's Disease. Biomolecules. vol 13. issue 11. 2023-11-25. PMID:38002258. brain-derived neurotrophic factor (bdnf) is a key molecule in promoting neurogenesis, dendritic and synaptic health, neuronal survival, plasticity, and excitability, all of which are disrupted in neurological and cognitive disorders such as alzheimer's disease (ad). 2023-11-25 2023-11-28 Not clear
Sama Jaberi, Margaret Fahnestoc. Mechanisms of the Beneficial Effects of Exercise on Brain-Derived Neurotrophic Factor Expression in Alzheimer's Disease. Biomolecules. vol 13. issue 11. 2023-11-25. PMID:38002258. here, we review recent literature on the mechanisms behind exercise-induced bdnf upregulation and its effects on improving learning and memory and on alzheimer's disease pathology. 2023-11-25 2023-11-28 Not clear
Laryssa Alves-Borba, Verónica Espinosa-Fernández, Ania Canseco-Rodríguez, Ana María Sánchez-Pére. ABA Supplementation Rescues IRS2 and BDNF mRNA Levels in a Triple-Transgenic Mice Model of Alzheimer's Disease. Journal of Alzheimer's disease reports. vol 7. issue 1. 2023-10-18. PMID:37849638. aba supplementation rescues irs2 and bdnf mrna levels in a triple-transgenic mice model of alzheimer's disease. 2023-10-18 2023-11-08 mouse
Laryssa Alves-Borba, Verónica Espinosa-Fernández, Ania Canseco-Rodríguez, Ana María Sánchez-Pére. ABA Supplementation Rescues IRS2 and BDNF mRNA Levels in a Triple-Transgenic Mice Model of Alzheimer's Disease. Journal of Alzheimer's disease reports. vol 7. issue 1. 2023-10-18. PMID:37849638. insulin resistance underlies alzheimer's disease (ad) by affecting neuroinflammation and brain-derived neurotrophic factor (bdnf) expression. 2023-10-18 2023-11-08 mouse
Francesco Angelucci, Katerina Veverova, Alžbeta Katonová, Martin Vyhnalek, Jakub Hor. Serum PAI-1/BDNF Ratio Is Increased in Alzheimer's Disease and Correlates with Disease Severity. ACS omega. vol 8. issue 39. 2023-10-09. PMID:37810633. tpa/plasmin not only prevents the accumulation of β-amyloid in the brain but also is involved in the synthesis of the brain-derived neurotrophic factor (bdnf), a neurotrophin whose levels are reduced in alzheimer. 2023-10-09 2023-10-15 Not clear
Francesco Angelucci, Katerina Veverova, Alžbeta Katonová, Martin Vyhnalek, Jakub Hor. Serum PAI-1/BDNF Ratio Is Increased in Alzheimer's Disease and Correlates with Disease Severity. ACS omega. vol 8. issue 39. 2023-10-09. PMID:37810633. in the present study, we compared bdnf serum levels in alzheimer patients with dementia to those in alzheimer patients with amnestic mild cognitive impairment and to cognitively healthy controls. 2023-10-09 2023-10-15 Not clear
Francesco Angelucci, Katerina Veverova, Alžbeta Katonová, Martin Vyhnalek, Jakub Hor. Serum PAI-1/BDNF Ratio Is Increased in Alzheimer's Disease and Correlates with Disease Severity. ACS omega. vol 8. issue 39. 2023-10-09. PMID:37810633. our results showed that bdnf serum levels are lower (13.7% less) and pai-1 levels are higher in alzheimer patients with dementia than in alzheimer patients with amnestic mild cognitive impairment patients (23% more) or controls (36% more). 2023-10-09 2023-10-15 Not clear
Francesco Angelucci, Katerina Veverova, Alžbeta Katonová, Martin Vyhnalek, Jakub Hor. Serum PAI-1/BDNF Ratio Is Increased in Alzheimer's Disease and Correlates with Disease Severity. ACS omega. vol 8. issue 39. 2023-10-09. PMID:37810633. our results suggest that increased pai-1 levels in alzheimer, by impairing the production of the bdnf, are implicated in disease progression. 2023-10-09 2023-10-15 Not clear
Bhavana Yerraguravagari, Naga Pavani Penchikala, Aravinda Sai Kolusu, Grandhi Sandeep Ganesh, Prasad Konduri, Kumar V S Nemmani, Pavan Kumar Samudral. Montelukast Ameliorates Scopolamine-induced Alzheimer's Disease: Role on Cholinergic Neurotransmission, Antioxidant Defence System, Neuroinflammation and Expression of BDNF. CNS & neurological disorders drug targets. 2023-10-02. PMID:37779395. montelukast ameliorates scopolamine-induced alzheimer's disease: role on cholinergic neurotransmission, antioxidant defence system, neuroinflammation and expression of bdnf. 2023-10-02 2023-10-07 Not clear
Deborah A Deliyannides, Jamie A Graff, Izael Niño, Seonjoo Lee, Mustafa M Husain, Brent P Forester, Elizabeth Crocco, Ipsit V Vahia, Davangere P Devanan. Effects of lithium on serum Brain-Derived Neurotrophic Factor in Alzheimer's patients with agitation. International journal of geriatric psychiatry. vol 38. issue 9. 2023-09-21. PMID:37732619. little is known, however, about the effects of lithium on bdnf in alzheimer's dementia (ad). 2023-09-21 2023-10-07 human